{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:46Z","timestamp":1761986506960},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.clindermatol.2017.10.016","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T06:47:02Z","timestamp":1507186022000},"page":"249-254","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Drug eruptions in the mature patient"],"prefix":"10.1016","volume":"36","author":[{"given":"Ronni","family":"Wolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branka","family":"Marinovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2017.10.016_bb0005","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/ije\/31.4.776","article-title":"Population ageing in the United States of America: implications for public programmes","volume":"31","author":"Wiener","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1377\/hlthaff.19.3.191","article-title":"Population aging: a comparison among industrialized countries","volume":"19","author":"Anderson","year":"2000","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0015","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.3399\/bjgp11X548929","article-title":"Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study","volume":"61","author":"Salisbury","year":"2011","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3122\/jabfm.2013.05.130012","article-title":"The prevalence of chronic diseases and multimorbidity in primary care practice: a PPRNet report","volume":"26","author":"Ornstein","year":"2013","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/epirev\/mxs009","article-title":"Multimorbidity in older adults","volume":"35","author":"Salive","year":"2013","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12916-015-0322-7","article-title":"The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010","volume":"13","author":"Guthrie","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5414\/CPP45643","article-title":"Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1","volume":"45","author":"Haider","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0045","doi-asserted-by":"crossref","first-page":"e98043","DOI":"10.1371\/journal.pone.0098043","article-title":"Prevalence and predictors of polypharmacy among Korean elderly","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0050","first-page":"2079","article-title":"A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting","volume":"9","author":"Alhawassi","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1023\/A:1015570104121","article-title":"Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies","volume":"24","author":"Beijer","year":"2002","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00228-015-1974-0","article-title":"Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features","volume":"72","author":"Pedros","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/pds.1565","article-title":"Adverse drug reaction-related hospitalisations: a population-based cohort study","volume":"17","author":"van der Hooft","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/bcp.12161","article-title":"Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients","volume":"77","author":"Cahir","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0080","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","article-title":"Incidence and preventability of adverse drug events among older persons in the ambulatory setting","volume":"289","author":"Gurwitz","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0085","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/bcp.12596","article-title":"Adverse drug reactions in special populations\u2014the elderly","volume":"80","author":"Davies","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40801-015-0054-1","article-title":"Adverse drug reaction reporting pattern in Turkey: analysis of the national database in the context of the first pharmacovigilance legislation","volume":"3","author":"Ozcan","year":"2016","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0095","first-page":"FC01","article-title":"Retrospective analysis of pattern of cutaneous adverse drug reactions in tertiary hospital of Pauri Garhwal","volume":"10","author":"Dimri","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0100","first-page":"228","article-title":"Adverse cutaneous drug reactions\u2014a clinico-demographic study in a tertiary care teaching hospital of the Kashmir Valley, India","volume":"18","author":"Qayoom","year":"2015","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0105","first-page":"20","article-title":"Adverse cutaneous drug reactions: clinical pattern and causative agents in a tertiary care center in South India","volume":"70","author":"Pudukadan","year":"2004","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0378-6323.38431","article-title":"Clinical study of cutaneous drug eruptions in 200 patients","volume":"74","author":"Raksha","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/08923970903213735","article-title":"Incidence of allergic diseases in an elderly population","volume":"32","author":"Ventura","year":"2010","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0120","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-4632.2005.02607.x","article-title":"The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients","volume":"45","author":"Yalcin","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0125","first-page":"395","article-title":"Drug-related hospital admissions\u2014an overview of frequency and clinical presentation","volume":"63","author":"Jenerowicz","year":"2006","journal-title":"Acta Pol Pharm"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2310\/7750.2013.12096","article-title":"Skin manifestations of outpatient adverse drug events in the United States: a national analysis","volume":"17","author":"Koelblinger","year":"2013","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0135","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40266-014-0209-x","article-title":"Cutaneous adverse drug reactions in the elderly: a retrospective analysis in Thailand","volume":"31","author":"Tuchinda","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0140","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1468-3083.2000.00167.x","article-title":"Incidence, prevalence and the rates of cutaneous reactions to drugs","volume":"14","author":"Bigby","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0145","first-page":"765","article-title":"Rates of cutaneous reactions to drugs","volume":"137","author":"Bigby","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.alit.2015.09.001","article-title":"Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients\u2014treatment and outcome","volume":"65","author":"Yamane","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.alit.2015.01.002","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: the Food and Drug Administration adverse event reporting system, 2004-2013","volume":"64","author":"Abe","year":"2015","journal-title":"Allergol Int"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0160","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/0019-5154.147834","article-title":"Severe cutaneous adverse drug reactions: a clinicoepidemiological study","volume":"60","author":"Sasidharanpillai","year":"2015","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0165","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/1346-8138.12499","article-title":"Clinical profiles of Stevens-Johnson syndrome among Thai patients","volume":"41","author":"Limpawattana","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0170","first-page":"S1","article-title":"Frequency and incidence of severe cutaneous adverse reactions in different age groups","volume":"20","author":"Mockenhaupt","year":"2011","journal-title":"Pharmacoepidem"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0175","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/ageing\/22.6.450","article-title":"Toxic epidermal necrolysis (Lyell syndrome) in 77 elderly patients","volume":"22","author":"Bastuji-Garin","year":"1993","journal-title":"Age Ageing"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0185","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.016_bb0190","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.burns.2014.02.006","article-title":"A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres","volume":"40","author":"Mahar","year":"2014","journal-title":"Burns"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X17302067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X17302067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T04:25:53Z","timestamp":1535343953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X17302067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0738081X17302067"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2017.10.016","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug eruptions in the mature patient","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2017.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}